Instil Bio, Inc.TILNASDAQ
Loading
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +0.04% | +0.34% | +0.44% | +1.43% | +3.86% |
| Weighted Average Shares Diluted Growth | +0.04% | +0.34% | +0.44% | +1.43% | +3.86% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | -71.08% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -19.90% | -19.06% | -22.48% | -21.52% | -22.30% |
| Book Value per Share Growth | -24.68% | -25.22% | -29.91% | -33.44% | -34.24% |
| Debt Growth | -1.06% | +0.97% | +1.00% | -0.86% | -0.50% |
| R&D Expense Growth | -93.38% | -44.58% | -25.98% | +130.85% | +1524.02% |
| SG&A Expenses Growth | -10.33% | -2.07% | -20.31% | -42.49% | -44.94% |